TherapeuticsMD (TXMD) Interest Expenses (2010 - 2025)

TherapeuticsMD has reported Interest Expenses for 12 years, with the latest figure at $3000.0 in Q3 2025.

• For the quarter ending Q3 2025, Interest Expenses changed 0.0% year-over-year to $3000.0; the trailing twelve-month figure through Mar 2026 stood at $5000.0 (down 50.0% YoY), and the FY2021 full-year result was $22.6 million, down 13.36% from the prior year.
• Interest Expenses for Q3 2025 stood at $3000.0, up from $2000.0 in the prior quarter.
• The five-year high for Interest Expenses was $14.4 million in Q1 2022, with the low at $2000.0 in Q1 2025.
• Historically, Interest Expenses has averaged $3.3 million across 5 years, with a median of $45000.0 in 2023.
• Annual changes were most pronounced in 2021 — Interest Expenses surged 63.32% — and 2023, when it tumbled 99.65%.
• TherapeuticsMD's Interest Expenses stood at $5.4 million in 2021, then jumped by 167.24% to $14.4 million in 2022, then slumped by 99.86% to $20000.0 in 2023, then plunged by 85.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
• The last three Interest Expenses figures came in at $3000.0 (Q3 2025), $2000.0 (Q2 2025), and $2000.0 (Q1 2025), per Business Quant data.